Intelligent Bio Solutions
INBS
13 hedge funds and large institutions have $416K invested in Intelligent Bio Solutions in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
63% more funds holding
Funds holding: 8 → 13 (+5)
20% more capital invested
Capital invested by funds: $347K → $416K (+$69K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
| 2 |
VF
Virtu Financial
New York
|
+$85.1K |
| 3 |
Renaissance Technologies
New York
|
+$64.4K |
| 4 |
Goldman Sachs
New York
|
+$41.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
WealthShield Partners
Cary,
North Carolina
|
-$71K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$56K |
| 3 |
Jane Street
New York
|
-$36K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $88K | +$108K | +47 | New |
|
|
VF
2
Virtu Financial
New York
| $70K | +$85.1K | +37 | New |
|
|
3
Renaissance Technologies
New York
| $53K | +$64.4K | +28 | New |
|
|
BCM
4
Bridgeway Capital Management
Houston,
Texas
| $39K | -$23K | -10 | -32% |
|
|
5
Goldman Sachs
New York
| $33K | +$41.4K | +18 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $28K | +$18.4K | +8 | +114% |
|
7
BlackRock
New York
| $24K | +$9.2K | +4 | +44% |
|
|
8
Citadel Advisors
Miami,
Florida
| $23K | +$27.6K | +12 | New |
|
9
Millennium Management
New York
| $22K | +$27.6K | +12 | New |
|
|
IWM
10
IHT Wealth Management
Chicago,
Illinois
| $16K | +$18.4K | +8 | New |
|
11
UBS Group
Zurich,
Switzerland
| $9K | +$2.3K | +1 | +25% |
|
12
State Street
Boston,
Massachusetts
| $8K | +$9.2K | +4 | New |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
|
WP
14
WealthShield Partners
Cary,
North Carolina
| – | -$71K | -20 | Closed |
|
|
15
Vanguard Group
Malvern,
Pennsylvania
| – | -$56K | -16 | Closed |
|
|
16
Jane Street
New York
| – | -$36K | -10 | Closed |
|
INBS Hedge Fund Activity: Q1 2022 in Review
13 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2022, worth a combined $416K — up 20% from $347K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new INBS positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $108K. The largest seller was WealthShield Partners, exiting entirely with an estimated $71K sold.
- 13 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2022, up from 8 in Q4 2021.
- Funds reported $416K of Intelligent Bio Solutions stock for Q1 2022, up 20% quarter-over-quarter.
- 8 funds opened new Intelligent Bio Solutions positions in Q1 2022 and 3 closed out, a net change of +5 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2022 was Geode Capital Management, an estimated $108K added.
- The largest Intelligent Bio Solutions seller in Q1 2022 was WealthShield Partners, an estimated $71K sold.
Based on aggregated 13F filings for Q1 2022.